Commentary

Find our newspaper columns, blogs, and other commentary pieces in this section. Our research focuses on Advanced Biology, High-Tech Geopolitics, Strategic Studies, Indo-Pacific Studies & Economic Policy

Advanced Biology, Public Health Guest User Advanced Biology, Public Health Guest User

Long Covid Among Kids: Numbers May Not Be Too High, But It’s a Big Risk to Ignore Its Threats

By Priyal Lyncia D’Almeida

Since the Covid-19 pandemic began, it has been clear that children are less severely affected by Sars-CoV-2 than adults. Coronavirus infections in children usually do not cause symptoms, or the symptoms are mild. Nevertheless, many children infected with the omicron variant of Sars-CoV-2, whether symptomatic or asymptomatic, show health effects, even months after the virus was first detected. Recent studies have shown that long Covid is prevalent in children infected with Sars-CoV-2. India started its vaccination campaign for kids above 12 in January 2022, but we need to drastically increase this coverage to protect children from long Covid.

Read More
Advanced Biology Priyal Lyncia D'Almeida Advanced Biology Priyal Lyncia D'Almeida

Why India shouldn't allow COVID-19 booster dose

The Delta variant caused a fresh wave of Covid-19 infections worldwide, aggravating the global public health catastrophe. The currently available Covid-19 vaccines are effective against the Delta variant, which prompted researchers to evaluate whether booster doses for vaccinated people are necessary and when they should be given. The objective of the booster dose is to extend vaccine efficacy in people already administered with primary vaccination. However, this decision should be taken after careful analysis of the necessity of boosters and their timing. India, however, should refrain from administering booster doses to its population until further studies are done to show its utility.Read the full article in the Deccan Herald

Read More